Going up in smoke: Tobacco smoking is associated with worse treatment outcomes in mania

Journal of Affective Disorders

Volumn 110, Issue 1-2, 2008, Pages 126-134

  Berk, Michael ^a,b,c,d   Ng, Felicity ^a,b   Wang, Wei V ^e   Tohen, Mauricio ^e,f   Lubman, Dan I ^a,c   Vieta, Eduard ^g   Dodd, Seetal ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BARWON HEALTH   (Australia)

^c ORYGEN RESEARCH CENTRE   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e ELI LILLY AND COMPANY   (United States)

^f MCLEAN HOSPITAL   (United States)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar disorder; Mania; Outcomes; Smoking; Tobacco; Treatment

Indexed keywords

HALOPERIDOL; OLANZAPINE; PLACEBO; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR MANIA; CIGARETTE SMOKING; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; COMORBIDITY; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; LEAST-SQUARES ANALYSIS; MALE; META-ANALYSIS AS TOPIC; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; SMOKING; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 47749092158     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.01.018     Document Type: Article

References (34)

1. American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Substance Use Disorders. 2nd edition (2006). http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm access date 27th Feb 2007, 2nd ed.
2. Berk M., Dodd S., Kauer-Sant'anna M., Malhi G.S., Bourin M., Kapczinski F., and Norman T. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr. Scand. 116 (2007) 41-49
3. Breslau N., Peterson E.L., Schultz L.R., Chilcoat H.D., and Andreski P. Major depression and stages of smoking. A longitudinal investigation. Arch. Gen. Psychiatry 55 (1998) 161-166
4. Cassidy F., Mcevoy J.P., Yang Y.K., and Wilson W.H. Smoking and psychosis in patients with bipolar I disorder. Compr. Psychiatry 43 (2002) 63-64
5. Chandra P.S., Carey M.P., Carey K.B., Jairam K.R., Girish N.S., and Rudresh H.P. Prevalence and correlates of tobacco use and nicotine dependence among psychiatric patients in India. Addict. Behav. 30 (2005) 1290-1299
6. Choi W.S., Patten C.A., Gillin J.C., Kaplan R.M., and Pierce J.P. Cigarette smoking predicts development of depressive symptoms among U.S. adolescents. Ann. Behav. Med. 19 (1997) 42-50
7. Corvin A., O'mahony E., O'regan M., Comerford C., O'connell R., Craddock N., and Gill M. Cigarette smoking and psychotic symptoms in bipolar affective disorder. Br. J. Psychiatry 179 (2001) 35-38
8. Dani J.A., and De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol. Biochem. Behav. 70 (2001) 439-446
9. De Luca V., Likhodi O., Van Tol H.H., Kennedy J.L., and Wong A.H. Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia. Acta Psychiatr. Scand. 114 (2006) 211-215
10. Desai H.D., Seabolt J., and Jann M.W. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs 15 (2001) 469-494
11. Diwan A., Castine M., Pomerleau C.S., Meador-Woodruff J.H., and Dalack G.W. Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders. Schizophr. Res. 33 (1998) 113-118
12. Fagerstrom K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs 62 Suppl. 2 (2002) 1-9
13. Fowler J.S., Logan J., Wang G.J., and Volkow N.D. Monoamine oxidase and cigarette smoking. Neurotoxicology 24 (2003) 75-82
14. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., and Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 61 (2004) 1107-1115
15. Hutchison K.E., Rutter M.C., Niaura R., Swift R.M., Pickworth W.B., and Sobik L. Olanzapine attenuates cue-elicited craving for tobacco. Psychopharmacology (Berl.) 175 (2004) 407-413
16. Johnson E.O., and Breslau N. Is the association of smoking and depression a recent phenomenon?. Nicotine Tob. Res. 8 (2006) 257-262
17. Kendler K.S., Neale M.C., Maclean C.J., Heath A.C., Eaves L.J., and Kessler R.C. Smoking and major depression. A causal analysis. Arch. Gen. Psychiatry 50 (1993) 36-43
18. Klungsoyr O., Nygard J.F., Sorensen T., and Sandanger I. Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. Am. J. Epidemiol. 163 (2006) 421-432
19. Laviolette S.R., and Van Der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat. Rev., Neurosci. 5 (2004) 55-65
20. Leonard S., Adler L.E., Benhammou K., Berger R., Breese C.R., Drebing C., Gault J., Lee M.J., Logel J., Olincy A., Ross R.G., Stevens K., Sullivan B., Vianzon R., Virnich D.E., Waldo M., Walton K., and Freedman R. Smoking and mental illness. Pharmacol. Biochem. Behav. 70 (2001) 561-570
21. Leonard S., Gault J., Hopkins J., Logel J., Vianzon R., Short M., Drebing C., Berger R., Venn D., Sirota P., Zerbe G., Olincy A., Ross R.G., Adler L.E., and Freedman R. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch. Gen. Psychiatry 59 (2002) 1085-1096
22. Malhi G.S., and Berk M. Does dopamine dysfunction drive depression?. Acta Psychiatr. Scand., Suppl. (2007) 116-124
23. Mallinckrodt C.H., Clark S.W., Carroll R.J., and Molenbergh G. Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations. J. Biopharm. Stat. 13 (2003) 179-190
24. Martin L.F., Leonard S., Hall M.H., Tregellas J.R., Freedman R., and Olincy A. Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. Am. J. Med. Genet. B., Neuropsychiatr. Genet. 144 (2007) 611-614
25. Olivier D., Lubman D.I., and Fraser R. Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective. Aust. N. Z. J. Psychiatry 41 (2007) 572-580
26. Ostacher M.J., Nierenberg A.A., Perlis R.H., Eidelman P., Borrelli D.J., Tran T.B., Marzilli Ericson G., Weiss R.D., and Sachs G.S. The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J. Clin. Psychiatry 67 (2006) 1907-1911
27. Tohen M., Sanger T.M., Mcelroy S.L., Tollefson G.D., Chengappa K.N., Daniel D.G., Petty F., Centorrino F., Wang R., Grundy S.L., Greaney M.G., Jacobs T.G., David S.R., and Toma V. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am. J. Psychiatry 156 (1999) 702-709
28. Tohen M., Baker R.W., Altshuler L.L., Zarate C.A., Suppes T., Ketter T.A., Milton D.R., Risser R., Gilmore J.A., Breier A., and Tollefson G.A. Olanzapine versus divalproex in the treatment of acute mania. Am. J. Psychiatry 159 (2002) 1011-1017
29. Tohen M., Goldberg J.F., Gonzalez-Pinto Arrillaga A.M., Azorin J.M., Vieta E., Hardy-Bayle M.C., Lawson W.B., Emsley R.A., Zhang F., Baker R.W., Risser R.C., Namjoshi M.A., Evans A.R., and Breier A. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch. Gen. Psychiatry 60 (2003) 1218-1226
30. Tohen M., Ketter T.A., Zarate C.A., Suppes T., Frye M., Altshuler L., Zajecka J., Schuh L.M., Risser R.C., Brown E., and Baker R.W. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am. J. Psychiatry 160 (2003) 1263-1271
31. Vanable P.A., Carey M.P., Carey K.B., and Maisto S.A. Smoking among psychiatric outpatients: relationship to substance use, diagnosis, and illness severity. Psychol. Addict. Behav. 17 (2003) 259-265
32. Vieta E., Colom F., Corbella B., Martinez-Aran A., Reinares M., Benabarre A., and Gasto C. Clinical correlates of psychiatric comorbidity in bipolar I patients. Bipolar Disord. 3 (2001) 253-258
33. Waxmonsky J.A., Thomas M.R., Miklowitz D.J., Allen M.H., Wisniewski S.R., Zhang H., Ostacher M.J., and Fossey M.D. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen. Hosp. Psych. 27 (2005) 321-328
34. Wu L.T., and Anthony J.C. Tobacco smoking and depressed mood in late childhood and early adolescence. Am. J. Public Health 89 (1999) 1837-1840